The archive · Bio & Materials · Technical decision · 2025–2026
Melazyme bets precision fermentation can make melanin and sweet protein a real business
Perfect Day alums found Melazyme to ferment melanin and sweet proteins; a $2M seed led by SeaX Ventures funds production scale-up.
Melazyme
What the business is
Melazyme uses precision fermentation to produce high-value functional biomolecules — melanin and the sweet protein brazzein — for cosmetics, food, filtration and industrial applications.
Starting capital：$2M seed (May 2026) led by SeaX Ventures, with Stellaris Venture Partners and Plug and Play Ventures
How it started
Perumal Gandhi, who co-founded Perfect Day, and Bonney Oommen, its former chief product and strategy officer, founded Melazyme in 2025 in Utah. Their bet: precision fermentation should move past whey protein to molecules where fermentation's control over function creates obvious value, starting with melanin and the sweet protein brazzein.
What happened
Melazyme developed a patent-pending fermentation platform that produces melanin at over 99% purity — versus 70-80% from cuttlefish extraction and about 75% from chemical synthesis — plus a heat-stable brazzein advanced with commercial partners. In May 2026 it closed a $2M seed led by Bangkok-based SeaX Ventures, with Stellaris Venture Partners and Plug and Play Ventures participating, to fund platform development, production scale-up and early commercial deployment.
No ending yet — it is still running.
Background
Melazyme is a Utah precision-fermentation startup founded in 2025 by Perumal Gandhi, co-founder of Perfect Day, and Bonney Oommen, Perfect Day's former chief product and strategy officer. Their bet is that fermentation should stop competing on commodity dairy protein and instead produce molecules where control over function is the differentiator.
Its two focus molecules are melanin and brazzein. Melanin is a naturally occurring biopolymer combining broad-spectrum UV absorption, chemical stability and strong affinity for metal ions, positioning it for cosmetics, coatings, filtration and rare-earth recovery; Melazyme says its fermentation process yields melanin at over 99% purity versus 70-80% from cuttlefish and about 75% from chemical synthesis. Brazzein is a heat-stable sweet protein from the West African Oubli fruit, 500-2,000 times sweeter than sucrose, being advanced with commercial partners.
In May 2026 Melazyme closed a $2M seed led by Bangkok-based deep-tech fund SeaX Ventures, with Stellaris Venture Partners and Plug and Play Ventures participating, to fund platform development, production scale-up and early commercial deployment. Near-term revenue is aimed at cosmetics, where its melanin precursor can bind hair keratin and restore natural color without ammonia or oxidative dyes.
The company's patent-pending platform is designed to tune molecular function for specific end uses, and it bets the precision-fermentation market will grow from roughly $20 billion today to over $70 billion by 2030. The seed only proves the thesis is fundable; Melazyme still has to show that its non-commodity molecules can be produced at commercial cost.
What has to be true
- Melanin's 99%+ purity versus 70-80% from cuttlefish and 75% from chemistry gave Melazyme a hard, measurable advantage to sell against.
- The founding team's Perfect Day experience meant the fermentation platform, strain selection and scale-up playbook already existed inside the company.
- Melanin's metal-ion affinity opens follow-on markets — filtration, heavy-metal remediation, rare-earth recovery — beyond the near-term cosmetics revenue.
- Brazzein's food-market runway lets the same platform serve two industries while the materials side matures.
What can be applied
Pick molecules where the new method beats incumbents on function, not price: melanin's 99% purity versus 70-80% from cuttlefish gave Melazyme a wedge extraction and chemistry can't copy.
Aftermath
As of September 2026 Melazyme is pre-commercial: the $2M seed is funding platform development, bioreactor scale-up and early deployments, with near-term revenue targeted at cosmetics and brazzein partnerships in food and beverage. The company projects the precision-fermentation market growing from about $20 billion today to over $70 billion by 2030, but its own production costs are not yet public.
Sources
- Perfect Day Alums Raise $2M for New Precision Fermentation Startup Melazyme
- Utah Startup Melazyme Raises $2M Seed Round to Produce Fermentation-Derived Melanin and Brazzein
- Melazyme advances precision fermentation platform for functional biomolecules, in seed round led by SeaX Ventures
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card